Showing results (61-70 of 458) with videos related to

Sort By:
Pageof 46
Preventive Medicine|July 9, 2018
How confident can we be in the current guidelines for exiting cervical screening?Patti E Gravitt, Rebecca Landy, Mark Schiffman
Obstetrics and Gynecology|June 3, 2008
Interobserver agreement in the assessment of components of colposcopic gradingL Stewart Massad, Jose Jeronimo, Mark Schiffman, et al.
International Journal of Cancer|January 4, 2012
Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3Ana Cecilia Rodríguez, Mark Schiffman, Rolando Herrero, et al.
Obstetrics and Gynecology Clinics of North America|December 7, 2007
Cervical cancer prevention--cervical screening: science in evolutionMahboobeh Safaeian, Diane Solomon, Philip E Castle
The Journal of Infectious Diseases|October 2, 2002
Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalitiesMark Schiffman, Cosette M Wheeler, Philip E Castle, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 9, 2015
Triage of HPV positive women in cervical cancer screeningNicolas Wentzensen, Mark Schiffman, Timothy Palmer, et al.
American Journal of Obstetrics and Gynecology|November 18, 2004
Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancerPhilip E Castle, Mark Schiffman, Cosette M Wheeler
Cancer Prevention Research (Philadelphia, Pa.)|December 1, 2023
Treatment of Cervical Precancers is the Major Remaining Challenge in Cervical Screening ResearchKanan T Desai, Silvia de Sanjosé, Mark Schiffman
Journal of the National Cancer Institute|February 17, 2010
Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infectionAna Cecilia Rodríguez, Mark Schiffman, Rolando Herrero, et al.
Pageof 46